BioCorRx To Launch New Weight Management Program
BioCorRx (OTCQB:BICX) has announced it will begin a pilot program for weight-loss with Atlantis Medical Wellness & Weight Loss Center in Silver Spring, MD. As quoted in the press release: The pilot program is expected to start on October 4, 2017. The Company expects to announce the name of its weight-loss program upon anticipated successful … Continued
BioCorRx (OTCQB:BICX) has announced it will begin a pilot program for weight-loss with Atlantis Medical Wellness & Weight Loss Center in Silver Spring, MD.
As quoted in the press release:
The pilot program is expected to start on October 4, 2017. The Company expects to announce the name of its weight-loss program upon anticipated successful completion of the pilot program in Q4 2017.
According to the CDC, more than one-third (36.5%) of U.S. adults have obesity. According to a 2012 article in the Journal of Health Economics, estimates of current healthcare costs of obesity range from $147 billion to nearly $210 billion per year. Some of the risks associated with this disease include heart disease and stroke, high blood pressure, metabolic syndrome, breathing problems and other health issues.
Dr. Benjamin Gonzalez, Medical Director of Atlantis Medical Wellness & Weight Loss Center, is renowned for his expertise in clinical nutrition with a focus on exercise nutrition and weight management. Dr. Gonzalez will be speaking at the A4M/MMI Weight Symposium on October 6-7, 2017 in Boston, MA. Information about the event can be found at https://www.a4m.com/weight-symposium-boston-2017.html. At this event, Dr. Gonzalez plans to introduce the potential benefits of the naltrexone implant for weight loss.
Dr. Gonzalez, stated, “We know how difficult losing weight can be. Our goal is to address the problems of the overweight and obese and enable individuals to regain control of their lives and health by giving them the necessary life skills to lose weight and achieve a healthy lifestyle. I’m very excited to introduce the implant as a potential groundbreaking medication therapy for weight loss providing sustained release naltrexone over many months.”
Click here to read the full press release.
